A Single-Center, Open-Label Study to Evaluate the Efficacy and Tolerability of Retinal Encapsulated in a Novel Biomimetic Exosome in the Treatment of Mild-To-Moderate Facial Photodamage. | Synapse
February 27, 2026
A Single-Center, Open-Label Study to Evaluate the Efficacy and Tolerability of Retinal Encapsulated in a Novel Biomimetic Exosome in the Treatment of Mild-To-Moderate Facial Photodamage.
Puntos clave
This research aims to assess the effectiveness and tolerability of retinal encapsulated in biomimetic exosomes for treating facial photodamage.
Single-center, open-label study design
Daily application of the retinal treatment
Evaluation of skin signs and irritation
Improved signs of facial photodamage were observed
None to mild skin irritation reported
Resumen
Daily use of this "hydrating retinal" improved signs of facial photodamage with none to mild signs of skin irritation.